カテゴリー： Transparency Market Research, 世界, 医療/バイオ

セントラルラボの世界市場2023～2031：製品別

◆英語タイトル：Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Transparency Market Researchが発行した調査報告書（TMR23JUL044）◆商品コード：TMR23JUL044
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2023年5月
◆ページ数：182
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥869,250見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,319,250見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,769,250見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の当調査レポートでは、世界のセントラルラボ市場規模が、2023年の26億ドルから2031年までに41億ドルに拡大し、予測期間中に年平均（CAGR）5.1%で成長すると推測しています。本書は、セントラルラボの世界市場について詳しく調査し、市場状況及び展望についてまとめています。序論、仮定・調査手法、エグゼクティブサマリー、市場動向、主要インサイト、製品別（遺伝子サービス、バイオマーカーサービス、微生物学サービス、解剖病理学/組織学、その他）分析、エンドユーザー別（製薬企業、バイオテクノロジー企業、学術・研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成で掲載しています。また、市場参入企業として、ACM Global Laboratories、Barc Lab (Cerba Research)、Bioscientia (Sonic Healthcare)、Celerion、CIRION BioPharma Research、Clinical Reference Laboratory、Eurofins Central Laboratory、Frontage Laboratories, Inc.、ICON Central Laboratoriesなどを含んでいます。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・主要インサイト
・世界のセントラルラボ市場規模：製品別
- 遺伝子サービスの市場規模
- バイオマーカーサービスの市場規模
- 微生物学サービスの市場規模
- 解剖病理学/組織学の市場規模
- その他製品の市場規模
・世界のセントラルラボ市場規模：エンドユーザー別
- 製薬企業における市場規模
- バイオテクノロジー企業における市場規模
- 学術・研究機関における市場規模
・世界のセントラルラボ市場規模：地域別
- 北米のセントラルラボ市場規模
- ヨーロッパのセントラルラボ市場規模
- アジア太平洋のセントラルラボ市場規模
- 中南米のセントラルラボ市場規模
- 中東・アフリカのセントラルラボ市場規模
・競争状況

Central Lab Market – Scope of Report
TMR’s report on the global Central Lab market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global Central Lab market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Central Lab market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the Central Lab market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Central Lab market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Central Lab market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global Central Lab market.

The report delves into the competitive landscape of the global Central Lab market. Key players operating in the global Central Lab market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Central Lab market profiled in this report.

Key Questions Answered in Global Central Lab Market Report
• What is the sales/revenue generated by Central Lab across all regions during the forecast period?
• What are the opportunities in the global Central Lab market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Central Lab Market – Research Objectives and Research Approach
The comprehensive report on the global Central Lab market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Central Lab market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global Central Lab market.

❖ レポートの目次 ❖

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Central Lab Market
4. Market Overview
    4.1. Introduction
        4.1.1. Product Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Central Lab Market Analysis and Forecast, 2017 – 2031
5. Key Insights
    5.1. Strategies Adopted by Top 3 Players
    5.2. Impact of Cell and Gene Therapy on Central Lab Market
    5.3. Impact of Clinical Trial on Central Lab Market
    5.4. COVID-19 Impact Analysis
6. Global Central Lab Market Analysis and Forecast, By Product
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Product, 2017 – 2031
        6.3.1. Genetic Services
        6.3.2. Biomarker Services
        6.3.3. Microbiology Services
        6.3.4. Anatomic Pathology/Histology
        6.3.5. Specimen Management & Storage
        6.3.6. Special Chemistry Services
        6.3.7. Clinical Research & Trial Services
        6.3.8. Others
    6.4. Market Attractiveness By Product
7. Global Central Lab Market Analysis and Forecast, By End-user
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By End-user, 2017 – 2031
        7.3.1. Pharmaceutical Companies
        7.3.2. Biotechnology Companies
        7.3.3. Academic & Research Institutes
    7.4. Market Attractiveness By End-user
8. Global Central Lab Market Analysis and Forecast, By Region
    8.1. Key Findings
    8.2. Market Value Forecast By Region
        8.2.1. North America
        8.2.2. Europe
        8.2.3. Asia Pacific
        8.2.4. Latin America
        8.2.5. Middle East & Africa
    8.3. Market Attractiveness By Country/Region
9. North America Central Lab Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast By Product, 2017 – 2031
        9.2.1. Genetic Services
        9.2.2. Biomarker Services
        9.2.3. Microbiology Services
        9.2.4. Anatomic Pathology/Histology
        9.2.5. Specimen Management & Storage
        9.2.6. Special Chemistry Services
        9.2.7. Clinical Research & Trial Services
        9.2.8. Others
    9.3. Market Value Forecast By End-user, 2017 – 2031
        9.3.1. Pharmaceutical Companies
        9.3.2. Biotechnology Companies
        9.3.3. Academic & Research Institutes
    9.4. Market Value Forecast By Country, 2017 – 2031
        9.4.1. U.S.
        9.4.2. Canada
    9.5. Market Attractiveness Analysis
        9.5.1. By Product
        9.5.2. By End-user
        9.5.3. By Country
10. Europe Central Lab Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast By Product, 2017 – 2031
        10.2.1. Genetic Services
        10.2.2. Biomarker Services
        10.2.3. Microbiology Services
        10.2.4. Anatomic Pathology/Histology
        10.2.5. Specimen Management & Storage
        10.2.6. Special Chemistry Services
        10.2.7. Clinical Research & Trial Services
        10.2.8. Others
    10.3. Market Value Forecast By End-user, 2017 – 2031
        10.3.1. Pharmaceutical Companies
        10.3.2. Biotechnology Companies
        10.3.3. Academic & Research Institutes
    10.4. Market Value Forecast By Country, 2017 – 2031
        10.4.1. Germany
        10.4.2. U.K.
        10.4.3. France
        10.4.4. Spain
        10.4.5. Italy
        10.4.6. Rest of Europe
    10.5. Market Attractiveness Analysis
        10.5.1. By Product
        10.5.2. By End-user
        10.5.3. By Country
11. Asia Pacific Central Lab Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Product, 2017 – 2031
        11.2.1. Genetic Services
        11.2.2. Biomarker Services
        11.2.3. Microbiology Services
        11.2.4. Anatomic Pathology/Histology
        11.2.5. Specimen Management & Storage
        11.2.6. Special Chemistry Services
        11.2.7. Clinical Research & Trial Services
        11.2.8. Others
    11.3. Market Value Forecast By End-user, 2017 – 2031
        11.3.1. Pharmaceutical Companies
        11.3.2. Biotechnology Companies
        11.3.3. Academic & Research Institutes
    11.4. Market Value Forecast By Country, 2017 – 2031
        11.4.1. China
        11.4.2. Japan
        11.4.3. India
        11.4.4. Australia & New Zealand
        11.4.5. Rest of Asia Pacific
    11.5. Market Attractiveness Analysis
        11.5.1. By Product
        11.5.2. By End-user
        11.5.3. By Country
12. Latin America Central Lab Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Product, 2017 – 2031
        12.2.1. Genetic Services
        12.2.2. Biomarker Services
        12.2.3. Microbiology Services
        12.2.4. Anatomic Pathology/Histology
        12.2.5. Specimen Management & Storage
        12.2.6. Special Chemistry Services
        12.2.7. Clinical Research & Trial Services
        12.2.8. Others
    12.3. Market Value Forecast By End-user, 2017 – 2031
        12.3.1. Pharmaceutical Companies
        12.3.2. Biotechnology Companies
        12.3.3. Academic & Research Institutes
    12.4. Market Value Forecast By Country, 2017 – 2031
        12.4.1. Brazil
        12.4.2. Mexico
        12.4.3. Rest of Latin America
    12.5. Market Attractiveness Analysis
        12.5.1. By Product
        12.5.2. By End-user
        12.5.3. By Country
13. Middle East & Africa Central Lab Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Product, 2017 – 2031
        13.2.1. Genetic Services
        13.2.2. Biomarker Services
        13.2.3. Microbiology Services
        13.2.4. Anatomic Pathology/Histology
        13.2.5. Specimen Management & Storage
        13.2.6. Special Chemistry Services
        13.2.7. Clinical Research & Trial Services
        13.2.8. Others
    13.3. Market Value Forecast By End-user, 2017 – 2031
        13.3.1. Pharmaceutical Companies
        13.3.2. Biotechnology Companies
        13.3.3. Academic & Research Institutes
    13.4. Market Value Forecast By Country, 2017 – 2031
        13.4.1. GCC Countries
        13.4.2. South Africa
        13.4.3. Rest of Middle East & Africa
    13.5. Market Attractiveness Analysis
        13.5.1. By Product
        13.5.2. By End-user
        13.5.3. By Country
14. Competition Landscape
    14.1. Market Player – Competition Matrix (By Tier and Size of companies)
    14.2. Market Share Analysis By Company (2022)
    14.3. Company Profiles
        14.3.1. ACM Global Laboratories
            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.1.2. Test Type Portfolio
            14.3.1.3. Financial Overview
            14.3.1.4. SWOT Analysis
            14.3.1.5. Strategic Overview
        14.3.2. Barc Lab (Cerba Research)
            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.2.2. Test Type Portfolio
            14.3.2.3. Financial Overview
            14.3.2.4. SWOT Analysis
            14.3.2.5. Strategic Overview
        14.3.3. Bioscientia (Sonic Healthcare)
            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.3.2. Test Type Portfolio
            14.3.3.3. Financial Overview
            14.3.3.4. SWOT Analysis
            14.3.3.5. Strategic Overview
        14.3.4. Celerion
            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.4.2. Test Type Portfolio
            14.3.4.3. Financial Overview
            14.3.4.4. SWOT Analysis
            14.3.4.5. Strategic Overview
        14.3.5. CIRION BioPharma Research
            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.5.2. Test Type Portfolio
            14.3.5.3. Financial Overview
            14.3.5.4. SWOT Analysis
            14.3.5.5. Strategic Overview
        14.3.6. Clinical Reference Laboratory
            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.6.2. Test Type Portfolio
            14.3.6.3. Financial Overview
            14.3.6.4. SWOT Analysis
            14.3.6.5. Strategic Overview
        14.3.7. Eurofins Central Laboratory
            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.7.2. Test Type Portfolio
            14.3.7.3. Financial Overview
            14.3.7.4. SWOT Analysis
            14.3.7.5. Strategic Overview
        14.3.8. Frontage Laboratories, Inc.
            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.8.2. Test Type Portfolio
            14.3.8.3. Financial Overview
            14.3.8.4. SWOT Analysis
            14.3.8.5. Strategic Overview
        14.3.9. ICON Central Laboratories
            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.9.2. Test Type Portfolio
            14.3.9.3. Financial Overview
            14.3.9.4. SWOT Analysis
            14.3.9.5. Strategic Overview
        14.3.10. INTERLAB Central Lab Services
            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.10.2. Test Type Portfolio
            14.3.10.3. Financial Overview
            14.3.10.4. SWOT Analysis
            14.3.10.5. Strategic Overview
        14.3.11. InVitro International
            14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.11.2. Test Type Portfolio
            14.3.11.3. Financial Overview
            14.3.11.4. SWOT Analysis
            14.3.11.5. Strategic Overview
        14.3.12. Labcorp/Covance
            14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.12.2. Test Type Portfolio
            14.3.12.3. Financial Overview
            14.3.12.4. SWOT Analysis
            14.3.12.5. Strategic Overview
        14.3.13. LabConnect
            14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.13.2. Test Type Portfolio
            14.3.13.3. Financial Overview
            14.3.13.4. SWOT Analysis
            14.3.13.5. Strategic Overview
        14.3.14. Medpace
            14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.14.2. Test Type Portfolio
            14.3.14.3. Financial Overview
            14.3.14.4. SWOT Analysis
            14.3.14.5. Strategic Overview
        14.3.15. MLM Medical Labs GmbH
            14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.15.2. Test Type Portfolio
            14.3.15.3. Financial Overview
            14.3.15.4. SWOT Analysis
            14.3.15.5. Strategic Overview
        14.3.16. PPD
            14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.16.2. Test Type Portfolio
            14.3.16.3. Financial Overview
            14.3.16.4. SWOT Analysis
            14.3.16.5. Strategic Overview
        14.3.17. Q² Solutions
            14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
            14.3.17.2. Test Type Portfolio
            14.3.17.3. Financial Overview
            14.3.17.4. SWOT Analysis
            14.3.17.5. Strategic Overview

List of Tables

Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031

Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ セントラルラボの世界市場2023～2031：製品別(Central Lab Market (Product: Genetic Services, Biomarker Services, Microbiology Services, Anatomic Pathology/Histology, Specimen Management & Storage, Special Chemistry Services, Clinical Research & Trial Services, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • ライム病診断の世界市場2023～2031：診断検査別、サンプル別
  • C反応性タンパク質検査の世界市場2023～2031：検査別、分析別
  • 遺伝子検査サービスの世界市場2023～2031：検査種類別
  • HIV/AIDS診断の世界市場（2022～2031）：製品別、検査種類別
  • 世界のインフルエンザ診断市場2023-2031：検査別（RT-PCR検査、インフルエンザ迅速診断検査、ウイルス培養、免疫蛍光アッセイ、血清学的検査、その他）

    • ◆H&Iグローバルリサーチのお客様（例）◆